Your browser doesn't support javascript.
loading
ADVANCE system testing: Benefit-risk analysis of a marketed vaccine using multi-criteria decision analysis and individual-level state transition modelling.
Bollaerts, Kaatje; Ledent, Edouard; de Smedt, Tom; Weibel, Daniel; Emborg, Hanne-Dorthe; Danieli, Giorgia; Duarte-Salles, Talita; Huerta-Alvarez, Consuelo; Martín-Merino, Elisa; Picelli, Gino; Tramontan, Lara; Sturkenboom, Miriam; Bauchau, Vincent.
Afiliação
  • Bollaerts K; P95 Epidemiology and Pharmacovigilance, Koning Leopold III laan, 1 3001 Heverlee, Belgium. Electronic address: kaatje.bollaerts@p-95.com.
  • Ledent E; GSK, Av. Fleming 20, 1300 Wavre, Belgium. Electronic address: edouard.y.ledent@gsk.com.
  • de Smedt T; P95 Epidemiology and Pharmacovigilance, Koning Leopold III laan, 1 3001 Heverlee, Belgium. Electronic address: tom.desmedt@p-95.com.
  • Weibel D; Erasmus University Medical Center, Post box 2040, 3000 CA Rotterdam, the Netherlands; VACCINE.GRID, Spitalstrasse 33, Basel, Switzerland. Electronic address: d.weibel@erasmusmc.nl.
  • Emborg HD; Statens Serum Institut, Artillerivej 5, 2300 Copenhagen, Denmark. Electronic address: HDE@ssi.dk.
  • Danieli G; Epidemiological Information for Clinical Research from an Italian Network of Family Paediatricians (PEDIANET), Padova, Italy.
  • Duarte-Salles T; Institut Universitari d'Investigació en Atenció Primària Jordi Gol (IDIAP Jordi Gol), Barcelona, Spain. Electronic address: tduarte@idiapjgol.org.
  • Huerta-Alvarez C; Base de Datos Para la Investigación Farmacoepidemiológica en Atención Primaria (BIFAP), Spanish Agency of Medicines and Medical Devices (AEMPS), Madrid, Spain. Electronic address: chuerta@aemps.es.
  • Martín-Merino E; Base de Datos Para la Investigación Farmacoepidemiológica en Atención Primaria (BIFAP), Spanish Agency of Medicines and Medical Devices (AEMPS), Madrid, Spain. Electronic address: emartinm@aemps.es.
  • Picelli G; Epidemiological Information for Clinical Research from an Italian Network of Family Paediatricians (PEDIANET), Padova, Italy. Electronic address: g.picelli@virgilio.it.
  • Tramontan L; Epidemiological Information for Clinical Research from an Italian Network of Family Paediatricians (PEDIANET), Padova, Italy. Electronic address: ltramontan@consorzioarsenal.it.
  • Sturkenboom M; P95 Epidemiology and Pharmacovigilance, Koning Leopold III laan, 1 3001 Heverlee, Belgium; VACCINE.GRID, Spitalstrasse 33, Basel, Switzerland; Julius Global Health, University Medical Center Utrecht, Heidelberglaan 100, the Netherlands. Electronic address: miriam.sturkenboom@p-95.com.
  • Bauchau V; GSK, Av. Fleming 20, 1300 Wavre, Belgium. Electronic address: vincent.g.bauchau@gsk.com.
Vaccine ; 38 Suppl 2: B65-B75, 2020 12 22.
Article em En | MEDLINE | ID: mdl-31677947
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacina contra Coqueluche / Coqueluche / Técnicas de Apoio para a Decisão Tipo de estudo: Etiology_studies / Health_economic_evaluation / Prognostic_studies / Risk_factors_studies Limite: Child / Humans País/Região como assunto: Europa Idioma: En Revista: Vaccine Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacina contra Coqueluche / Coqueluche / Técnicas de Apoio para a Decisão Tipo de estudo: Etiology_studies / Health_economic_evaluation / Prognostic_studies / Risk_factors_studies Limite: Child / Humans País/Região como assunto: Europa Idioma: En Revista: Vaccine Ano de publicação: 2020 Tipo de documento: Article